-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下:我們將目標股價從36美元上調至42美元,相當於2027年每股收益預測值3.09美元的13.6倍,高於TEVA的歷史平均預期市盈率,我們認為,其不斷改善的成長前景是合理的。我們將2026年每股盈餘預期從2.77美元下調至2.11美元,以調整Emalex收購的影響。我們維持2027年每股盈餘預期3.09美元不變。 Teva公佈了穩健的第一季業績,超越預期,這主要得益於其創新成長引擎(AUSTEDO、AJOVY和UZEDY)的持續強勁表現,這三款產品合計增長41%,成功抵消了仿製藥REVLIMID失去獨家銷售權帶來的預期收入下降。我們認為,新宣布的以7億美元收購Emalex的交易(預計將於第三季完成)是一項重要的策略舉措,也是一個重大利好。該交易將把已獲得新藥申請(NDA)資格的、同類首創的先導化合物Ecopipam(用於治療圖雷特綜合徵,該疾病目前存在巨大的未滿足醫療需求)納入梯瓦的神經科學產品線。我們認為,此次收購將加速梯瓦向創新、高利潤產品的轉型。
Related Articles
Research Alert: Oled Delivers Disappointing Results, Stable Guidance As Demand Remains Weak
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:OLED reported challenging Q1 results with revenue declining 14.5% Y/Y to $142M, well short of consensus expectations ($161M), while EPS of $0.76 fell 44% Y/Y and missed Street estimates ($1.20). The weakness was broad-based, with material sales down 2.9% to $84M and royalty/license fees declining 26.4% to $54M, representing the largest drag on quarterly performance. Management lowered 2026 revenue guidance to $650M from a prior $675M view, citing weak demand conditions. CFO noted near-term market conditions have become more measured while maintaining confidence in longer-term growth prospects, including Gen 8.6 capacity additions in Korea and China expected online this year. We agree with management's longer-term optimism but note weak current conditions may slow new OLED fab ramp timelines. We think the revised Q2-Q4 implied performance ($508M) creates room for downside risk below company projections, as the environment remains volatile.
China Shipbuilding Industry's 2025 Profit Slips 7%, Revenue Rises 12%
China Shipbuilding Industry Group Power's (SHA:600482) net profit attributable to shareholders in 2025 slipped 6.5% to 1.30 billion yuan from 1.39 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share declined 4.9% year on year to 0.58 yuan from 0.61 yuan.The Chinese shipbuilding conglomerate's operating revenue rose 12% to 57.80 billion yuan from 51.70 billion yuan in the prior year.
Mercuria Files Lawsuit Against Baltic Exchange Over TD3C Shipping Benchmark
Mercuria Energy Group said it has filed a lawsuit in London's High Court against Baltic Exchange Information Services, alleging distortion of a key oil shipping benchmark, Bloomberg reported on Thursday.The dispute centers on the TD3C route, which tracks the cost of shipping crude from the Middle East to China.Mercuria said the rate "no longer accurately or reliably represents the underlying market it is intended to measure," according to the claim form seen by Bloomberg, adding that the impact has led to losses estimated in the "hundreds of millions of US dollars."The Baltic Exchange, owned by Singapore Exchange, publishes freight rates widely used in global oil markets and derivatives trading.